Department of Medicine, Edendale Hospital, Pietermaritzburg, South Africa.
Int J Tuberc Lung Dis. 2011 Jul;15(7):919-24. doi: 10.5588/ijtld.10.0440.
Outcomes from the World Health Organization's (WHO's) recommendations for the diagnosis of smear-negative tuberculosis (SNTB) in high human immunodeficiency virus prevalence settings are unknown.
We retrospectively applied the WHO algorithm for SNTB without danger signs to a prospectively enrolled cohort of ambulatory adult SNTB suspects in KwaZulu-Natal, South Africa. Participants fulfilling specified criteria for SNTB started empiric anti-tuberculosis treatment; the rest of the cohort was observed. All were followed for 8 weeks. Confirmed TB was defined as positive culture or granulomata plus acid-fast bacilli on histology.
In total, 221 participants retrospectively fulfilled the WHO ambulatory SNTB algorithm entry criteria. The diagnostic performance of the WHO algorithm was: positive predictive value 0.34 (95%CI 0.26-0.43), negative predictive value 0.86 (95%CI 0.76-0.92), positive likelihood ratio 1.43 (95%CI 1.34-1.48), negative likelihood ratio 0.46 (95%CI 0.38-0.56) and diagnostic odds 3.1 (95%CI 1.52-6.34). Losses to follow-up (n = 4), hospitalisations (n = 6) and deaths (n = 5) did not differ significantly in those who were and were not diagnosed with SNTB.
The WHO ambulatory SNTB algorithm had a reasonably high negative predictive value but low positive predictive value. Mortality over an 8-week period was low in participants who met the entry criteria for the WHO algorithm.
世界卫生组织(WHO)关于在高人类免疫缺陷病毒流行环境下诊断涂片阴性肺结核(SNTB)的建议的结果尚不清楚。
我们回顾性地将 WHO 无危险迹象的 SNTB 算法应用于南非夸祖鲁-纳塔尔省前瞻性招募的门诊 SNTB 疑似患者队列中。符合 SNTB 特定标准的参与者开始接受经验性抗结核治疗;队列的其余部分则进行观察。所有患者均随访 8 周。确诊结核病定义为培养阳性或组织学上有肉芽肿和抗酸杆菌。
共有 221 名参与者符合 WHO 门诊 SNTB 算法的纳入标准。WHO 算法的诊断性能为:阳性预测值为 0.34(95%CI 0.26-0.43),阴性预测值为 0.86(95%CI 0.76-0.92),阳性似然比为 1.43(95%CI 1.34-1.48),阴性似然比为 0.46(95%CI 0.38-0.56),诊断优势比为 3.1(95%CI 1.52-6.34)。在符合和不符合 SNTB 诊断标准的患者中,失访(n=4)、住院(n=6)和死亡(n=5)的比例没有显著差异。
WHO 门诊 SNTB 算法具有较高的阴性预测值,但阳性预测值较低。符合 WHO 算法纳入标准的患者在 8 周内的死亡率较低。